Literature DB >> 2261204

Reversible oedema and necrosis after irradiation of the brain. Diagnostic procedures and clinical manifestations.

K Watne1, B Hager, M Heier, H Hirschberg.   

Abstract

One hundred and twelve patients with primary brain tumour were followed every 3 months during and after brain irradiation and chemotherapy with brain scanning, EEG and neurological examination. Early delayed radiation reactions were seen in 6 patients. The symptoms developed 2-8 months after irradiation and lasted for 2-3 months. Two types of reactions were observed. One mild form appeared after 2-3 months and was characterized by low-attenuated expansive areas within the irradiated volume, without contrast enhancement on CT scan. Severe reactions appeared in some patients after 6 months, with exacerbation of earlier clinical signs and contrast enhancing lesions on CT. Regression of the CT finding was seen after 3 months. Recognition of this syndrome is important, as a new neurosurgical procedure might cause lasting neurological sequelae in patients who otherwise would recover without treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2261204     DOI: 10.3109/02841869009096385

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

Review 1.  New advances that enable identification of glioblastoma recurrence.

Authors:  Isaac Yang; Manish K Aghi
Journal:  Nat Rev Clin Oncol       Date:  2009-10-06       Impact factor: 66.675

Review 2.  Pros and cons of current brain tumor imaging.

Authors:  Benjamin M Ellingson; Patrick Y Wen; Martin J van den Bent; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

3.  Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma.

Authors:  R J Young; A Gupta; A D Shah; J J Graber; Z Zhang; W Shi; A I Holodny; A M P Omuro
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

4.  Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas.

Authors:  Shin-Ichi Miyatake; Shinji Kawabata; Naosuke Nonoguchi; Kunio Yokoyama; Toshihiko Kuroiwa; Hideki Matsui; Koji Ono
Journal:  Neuro Oncol       Date:  2009-03-16       Impact factor: 12.300

5.  Rapid progression of early delayed radiation effect in pleomorphic xanthoastrocytoma.

Authors:  Kyung Jae Park; Shin-Hyuk Kang; Hoon Kap Lee; Yong Gu Chung
Journal:  J Korean Neurosurg Soc       Date:  2009-12-31

Review 6.  Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?

Authors:  Amanda J Walker; Jake Ruzevick; Ashkan A Malayeri; Daniele Rigamonti; Michael Lim; Kristin J Redmond; Lawrence Kleinberg
Journal:  Future Oncol       Date:  2014-05       Impact factor: 3.404

Review 7.  Malignant gliomas: old and new systemic treatment approaches.

Authors:  Tanja Mesti; Janja Ocvirk
Journal:  Radiol Oncol       Date:  2016-04-23       Impact factor: 2.991

Review 8.  Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.

Authors:  Jiayi Zeng; Xiangxue Li; Max Sander; Haipeng Zhang; Guangmei Yan; Yuan Lin
Journal:  Front Immunol       Date:  2021-10-05       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.